Accueil>>Signaling Pathways>> GPCR/G protein>> mGluR >>L-AP4

L-AP4 (Synonyms: L(+)2amino4phosphorobutanoic acid, LAPB)

Catalog No.GC17932

L-AP4 (L-APB) est un agoniste puissant et spécifique des mGluR du groupe III, avec des EC50 de 0,13, 0,29, 1,0, 249 μM pour les récepteurs mGlu4, mGlu8, mGlu6 et mGlu7, respectivement .

Products are for research use only. Not for human use. We do not sell to patients.

L-AP4 Chemical Structure

Cas No.: 23052-81-5

Taille Prix Stock Qté
1mg
70,00 $US
En stock
5mg
138,00 $US
En stock
10mg
241,00 $US
En stock
50mg
1 028,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

L-APB is a potent and specific agonist for the group III mGluRs, with EC50s of 0.13, 0.29, 1.0, 249 μM for mGlu4, mGlu8, mGlu6 and mGlu7 receptors, respectively.

Paw withdrawal threshold in response to application of von Frey filaments before spinal nerve ligation is 22.6±2.4 g. The mechanical threshold decreases significantly (2.3±0.5 g, P

References:
[1]. Selvam C, et al. Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites. J Med Chem. 2018 Mar 8;61(5):1969-1989.
[2]. Chen SR, et al. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured Rats. J Pharmacol Exp Ther. 2005 Jan;312(1):120-6.

Avis

Review for L-AP4

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for L-AP4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.